Citadel Advisors’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,297
Closed -$245K 14654
2026
Q1
$245K Buy
+6,297
New +$255K ﹤0.01% 10954
2025
Q4
Sell
-12,038
Closed -$486K 13837
2025
Q3
$486K Sell
12,038
-5,113
-30% -$197K ﹤0.01% 9210
2025
Q2
$631K Buy
17,151
+2,450
+17% +$83K ﹤0.01% 8085
2025
Q1
$488K Sell
14,701
-2,856
-16% -$99.3K ﹤0.01% 8526
2024
Q4
$608K Buy
+17,557
New +$616K ﹤0.01% 8134
2022
Q4
Sell
-14,531
Closed -$307K 15352
2022
Q3
$307K Buy
14,531
+652
+5% +$15.2K ﹤0.01% 9525
2022
Q2
$309K Buy
13,879
+5,386
+63% +$129K ﹤0.01% 9739
2022
Q1
$220K Buy
+8,493
New +$218K ﹤0.01% 11300

Other funds holding RECS

Citadel Advisors's RECS Position: Q2 2026 in Review

Citadel Advisors sold out of Columbia Research Enhanced Core ETF (RECS) in Q2 2026, closing a stake of 6,297 shares — an estimated $245K sold.

Citadel Advisors first reported a position in RECS in Q1 2022 and held it in 8 quarters. The position peaked at $631K in Q2 2025. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Citadel Advisors reported no remaining Columbia Research Enhanced Core ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 6,297 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $245K.
  • Citadel Advisors first reported a position in Columbia Research Enhanced Core ETF in Q1 2022 and held it in 8 quarters.
  • Citadel Advisors's Columbia Research Enhanced Core ETF position peaked at $631K in Q2 2025.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.